1. Home
  2. WGS vs FSK Comparison

WGS vs FSK Comparison

Compare WGS & FSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

N/A

Current Price

$70.96

Market Cap

2.7B

Sector

Technology

ML Signal

N/A

Logo FS KKR Capital Corp.

FSK

FS KKR Capital Corp.

N/A

Current Price

$11.11

Market Cap

3.0B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
WGS
FSK
Founded
2017
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Investment Managers
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.0B
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
WGS
FSK
Price
$70.96
$11.11
Analyst Decision
Strong Buy
Hold
Analyst Count
9
11
Target Price
★ $90.44
$12.05
AVG Volume (30 Days)
645.5K
★ 1.4M
Earning Date
10-27-2026
11-04-2026
Dividend Yield
N/A
★ 18.56%
EPS Growth
★ 62.37
N/A
EPS
N/A
★ N/A
Revenue
★ $427,539,000.00
N/A
Revenue This Year
$12.70
N/A
Revenue Next Year
$24.31
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 39.97
N/A
52 Week Low
$32.21
$9.72
52 Week High
$170.87
$16.31

Technical Indicators

Market Signals
Indicator
WGS
FSK
Relative Strength Index (RSI) 36.98 35.35
Support Level $71.85 $10.41
Resistance Level $94.82 $11.22
Average True Range (ATR) 6.64 0.25
MACD -3.00 -0.08
Stochastic Oscillator 4.57 20.77

Price Performance

Historical Comparison
WGS
FSK

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

About FSK FS KKR Capital Corp.

FS KKR Capital Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation. The company's portfolio is comprised of investments in senior secured loans and second lien secured loans of private middle market U.S. companies and, to a lesser extent, subordinated loans and certain asset-based financing loans of private U.S. companies.

Share on Social Networks: